Research Articles
The Green Danger: How Unripe Papaya's Hidden Toxin Wreaks Havoc on Cellular Power Plants
Discover how unripe papaya's hidden toxin targets liver mitochondria, disrupting cellular energy production and triggering cell death pathways.
The Unhealing Wound: When Your Lungs Can't Stop Sounding the Alarm
Exploring how Danger-Associated Molecular Patterns drive the relentless scarring in Idiopathic Pulmonary Fibrosis and the promising research that could lead to new treatments.
Training the Body's Assassins: A New Front in the Fight Against Mesothelioma
How scientists are using a clever cellular trick to turn cancer against itself through apoptotic cell-pulsed dendritic cell vaccination.
The Gut Hormone Siblings: One Fights Diabetes, The Other Heals Your Gut
Explore how GLP-1 and GLP-2, two nearly identical gut hormones, send very different signals to regulate metabolism and gut health.
GSK-3 Inhibitors: The Diabetes Heart Dilemma
Exploring the delicate balance between therapeutic potential and cardiac safety in GSK-3 inhibitors for diabetes treatment.
The Guardian's Dilemma: How p53 Stops Cells from Self-Destructing
Discover how p53 protein prevents mitotic catastrophe in cells exposed to ionizing radiation, ensuring controlled cell death and genomic stability.
Unlocking Cancer's Self-Destruct Button: How a Cholesterol Drug Fights Childhood Brain Tumors
Exploring how lovastatin, a cholesterol-lowering drug, induces apoptosis in medulloblastoma by altering cell-cycle gene expression
The Tiny Guardian of Your Heart: How a Microscopic Molecule Fights Damage
Discover how MiR-135a, a tiny microRNA molecule, protects your heart from injury by targeting the inflammatory TLR4 pathway.
The Evolvable Enemy: How Lung Cancer Outsmarts Targeted Therapy
Explore the molecular mechanisms of resistance to tyrosine kinase-targeted therapy in non-small cell lung cancer and how cancer cells evolve to survive treatment.
The Cellular Sabotage: How Silenced MicroRNAs Fuel Blood Cancer
Discover how epigenetic inactivation of miR-9 in chronic lymphocytic leukemia leads to constitutive activation of the NFκB pathway, driving cancer progression.